These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 25856745)

  • 61. Aripiprazole and haloperidol: a clinically relevant interaction with a dopamine antagonist and partial agonist.
    Burke MJ; Lincoln J
    Ann Clin Psychiatry; 2006; 18(2):129-30. PubMed ID: 16754419
    [No Abstract]   [Full Text] [Related]  

  • 62. Association of serum iron and serum CPK in acute psychosis.
    Gurrera RJ
    J Clin Psychopharmacol; 2006 Aug; 26(4):436-8. PubMed ID: 16855468
    [No Abstract]   [Full Text] [Related]  

  • 63. [Huntington's disease: a negative family history case report demonstrating reduction of psychiatric symptoms with olanzapine].
    Coelho VA; Beato RG; Prado PH; Cardoso FE; Lauar H
    Braz J Psychiatry; 2009 Jun; 31(2):186-8. PubMed ID: 19578696
    [No Abstract]   [Full Text] [Related]  

  • 64. Understanding HD Psychosis: An Analysis from the ENROLL-HD Database.
    Jaini A; Yomtoob J; Yeh C; Bega D
    Tremor Other Hyperkinet Mov (N Y); 2020 Jul; 10():16. PubMed ID: 32775030
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neuropsychiatric aspects of Huntington's disease.
    Paulsen JS; Ready RE; Hamilton JM; Mega MS; Cummings JL
    J Neurol Neurosurg Psychiatry; 2001 Sep; 71(3):310-4. PubMed ID: 11511702
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Risperidone in chorea and psychosis of Huntington's disease.
    Erdemoglu AK; Boratav C
    Eur J Neurol; 2002 Mar; 9(2):182-3. PubMed ID: 11882064
    [No Abstract]   [Full Text] [Related]  

  • 67. Treatment of the psychiatric manifestations of Huntington's disease: a review of the literature.
    Leroi I; Michalon M
    Can J Psychiatry; 1998 Nov; 43(9):933-40. PubMed ID: 9825166
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Management of acute psychosis.
    Fitzgerald PB
    Aust N Z J Psychiatry; 2000 Oct; 34(5):876-7. PubMed ID: 11037383
    [No Abstract]   [Full Text] [Related]  

  • 69. Clozapine treatment of psychiatric symptoms resistant to neuroleptic treatment in patients with Huntington's chorea.
    Sajatovic M; Verbanac P; Ramirez LF; Meltzer HY
    Neurology; 1991 Jan; 41(1):156. PubMed ID: 1670739
    [No Abstract]   [Full Text] [Related]  

  • 70. [Frontal dysfunctions in Huntington's disease -- neuropsychology and therapy].
    Weimer E; Ries S; Tost H; Braus DF
    Psychiatr Prax; 2003 Jan; 30(1):33-6. PubMed ID: 12524580
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Meditation induced psychosis: Case report.
    Prakash R; Aggarwal N; Kataria D; Prasad S
    Asian J Psychiatr; 2018 Jan; 31():109-110. PubMed ID: 29475163
    [No Abstract]   [Full Text] [Related]  

  • 72. [Huntington disease. Current state of research].
    Petit H; Pasquier F
    Presse Med; 1994 Feb; 23(8):385-91. PubMed ID: 8208706
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A review of the treatment options for Huntington's disease.
    Bonelli RM; Hofmann P
    Expert Opin Pharmacother; 2004 Apr; 5(4):767-76. PubMed ID: 15102562
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Persistent psychotic disorder in an adolescent with a past history of butane gas dependence.
    Jung IK; Lee HJ; Cho BH
    Eur Psychiatry; 2004 Dec; 19(8):519-20. PubMed ID: 15589716
    [No Abstract]   [Full Text] [Related]  

  • 75. Onset of psychosis following strokes to the cerebellum and thalamus.
    Liao PC; Wei CJ; Chen PH
    Psychosomatics; 2018; 59(4):413-414. PubMed ID: 29054750
    [No Abstract]   [Full Text] [Related]  

  • 76. Non-pharmacological treatments in a patient with dementia due to Huntington's disease.
    Lee HM; Chen ST; Chen SJ
    J Neuropsychiatry Clin Neurosci; 2010; 22(2):E17. PubMed ID: 20463131
    [No Abstract]   [Full Text] [Related]  

  • 77. Proglumide, a cholecystokinin receptor antagonist, reduces neuroleptic action in Huntington's chorea.
    Piolti R; Appollonio I; Perego M; Pozzi C; Rovati L; Ferrarese C; Frattola L
    Eur Neurol; 1995; 35(6):344-8. PubMed ID: 8591802
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Motor Dysfunction as a Risk Factor for Conversion to Psychosis Independent of Medication Use in a Psychosis-Risk Cohort.
    Masucci MD; Lister A; Corcoran CM; Brucato G; Girgis RR
    J Nerv Ment Dis; 2018 May; 206(5):356-361. PubMed ID: 29561299
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Understanding the neuropsychiatric symptoms of Huntington's disease.
    Hofmann N
    J Neurosci Nurs; 1999 Oct; 31(5):309-13. PubMed ID: 10633308
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Psychosis in a female patient with tuberous sclerosis.
    Tasdemir A; Kalelioglu T; Genc A; Kalelioglu T; Umut G
    J Neuropsychiatry Clin Neurosci; 2013; 25(2):E61. PubMed ID: 23686070
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.